ArticleNature communications2025
Disentangling the mechanistic role of loop-C capping in Cys-loop receptor activation.
Article in Nature communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
A comparison of atomic models of Cys-loop receptors reveals that the largest rearrangement upon agonist binding and gating is the contraction ("capping") of the neurotransmitter binding-site loop C. The capping of this loop has often been suggested to act as the mechanical link that couples the binding of extracellular ligands to the gating of the transmembrane pore. However, because binding and gating are inextricably linked, testing this idea experimentally has proved challenging. Here, we disentangle binding and gating using mutagenesis, chimeric constructs, and functional assays. Our results point to the notion that loop-C capping is not required for the pore of Cys-loop receptors to open/desensitize in response to agonist binding to the extracellular domain. Instead, the functional impact of this marked rearrangement seems to be confined to local changes at the level of the neurotransmitter-binding sites, such as the transition from the unliganded state to the low-affinity agonist-bound conformation and/or the transition from the latter to the high-affinity bound state.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.